XML 42 R29.htm IDEA: XBRL DOCUMENT v2.4.0.8
Acquisitions (Tables) (Agila Specialties)
6 Months Ended
Jun. 30, 2014
Agila Specialties
 
Business Acquisition [Line Items]  
Schedule of Purchase Price Allocation
The allocation of the $1.43 billion purchase price to the assets acquired and liabilities assumed for Agila is as follows:

(In millions)
 
 
Current assets (excluding inventories)
 
$
45.5

Inventories
 
37.3

Property, plant and equipment
 
146.2

Identified intangible assets
 
280.0

In-process research and development
 
436.0

Goodwill
 
936.6

Other assets (including equity method investment)
 
152.8

Total assets acquired
 
2,034.4

Current liabilities
 
(242.0
)
Deferred tax liabilities
 
(235.1
)
Other non-current liabilities
 
(123.6
)
Net assets acquired
 
$
1,433.7


Business Acquisition, Pro Forma Information for Agila Acquisition
The following table presents supplemental unaudited pro forma information as if the acquisition of Agila had occurred on January 1, 2012. The unaudited pro forma results reflect certain adjustments related to past operating performance and acquisition accounting adjustments, such as increased amortization expense based on the fair valuation of assets acquired, the impact of acquisition financing, and the related income tax effects. The unaudited pro forma results do not include any anticipated synergies which may be achievable subsequent to the acquisition date. Accordingly, the unaudited pro forma results are not necessarily indicative of the results that actually would have occurred had the acquisition been completed on January 1, 2012, nor are they indicative of the future operating results of the combined company.

 
Three Months Ended
 
Six Months Ended
(In millions, except per share amounts)
June 30,
2013
 
June 30,
2013
Total revenues
$
1,751.9

 
$
3,445.8

Net earnings attributable to Mylan Inc. common shareholders
$
145.7

 
$
229.7

Earnings per common share attributable to Mylan Inc. common shareholders:

 
 
Basic
$
0.38

 
$
0.59

Diluted
$
0.37

 
$
0.58

Weighted average common shares outstanding:

 
 
Basic
381.2

 
387.2

Diluted
387.1

 
393.0